GEN Exclusives

More »
Insight & Intelligence™

Related to Footprint-Free, Site-Specific Gene Editing

  • Gene Editing with Multiple Molecular Means
    This first part of a two-part article on treating Duchenne muscular dystrophy focuses on a potential new treatment that interferes with nonsense mutations.
  • Six Websites You Need to Bookmark
    Check out these websites from GEN's Best of the Web.
  • CRISPR/Cas Comes of Age—Almost
    Genetic tools based on components of a bacterial adaptive immune system may offer a set of novel tools for adding, deleting, or replacing specific genes in model organisms.
  • Gene Editing Typos
    Researchers use a human cell-based reporter assay to characterize off-target cleavage of CRISPR-associated (Cas)9-based RNA-guided nucleases.
  • Accessible TALENs
    The FLASH system is a rapid and cost-effective method for large-scale assembly of transcription activator-like effector nucleases.
  • Gene Editing to Treat Genetic Diseases, Part II
    This second part of a two-part article on treating Duchenne muscular dystrophy discusses TALENs and TAL effectors as possible treatments.
  • CRISPR Madness
    Scientists are working out the kinks of this breakthrough technology.
  • Page 1 of 1 (7 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?